Novo Digs In to Protect Its No. 1 Spot in Obesity Pill Market

This is a live story built from multiple sources. It may evolve quickly.

Coverage meter • 1 min window

Back to home Open top source

B bloomberg.com

What’s included

Top recent items from this story.

1 items • 1 unique links

Bloomberg Markets 4 days ago • bloomberg.com

Novo Digs In to Protect Its No. 1 Spot in Obesity Pill Market

Earlier this year, Novo Nordisk A/S pulled off the best obesity-drug launch ever with its Wegovy pill. Now it’s focused on building on more than 600,000 prescriptions as Eli Lilly & Co. threatens to siphon patients away…

Open